| The HIF and other quandaries in VHL disease D Tarade, M Ohh Oncogene 37 (2), 139-147, 2018 | 85 | 2018 |
| HIF-2α-pVHL complex reveals broad genotype-phenotype correlations in HIF-2α-driven disease D Tarade, CM Robinson, JE Lee, M Ohh Nature Communications 9 (1), 3359, 2018 | 40 | 2018 |
| Cancer cell mitochondria targeting by pancratistatin analogs is dependent on functional complex II and III D Ma, C Pignanelli, D Tarade, T Gilbert, M Noel, F Mansour, S Adams, ... Scientific reports 7, 42957, 2017 | 40 | 2017 |
| Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest D Tarade, D Ma, C Pignanelli, F Mansour, D Simard, S van den Berg, ... PLoS One 12 (3), e0171806, 2017 | 35 | 2017 |
| Evolution of metazoan oxygen-sensing involved a conserved divergence of VHL affinity for HIF1α and HIF2α D Tarade, JE Lee, M Ohh Nature Communications 10 (1), 3293, 2019 | 24 | 2019 |
| Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata M Ohh, CC Taber, FG Ferens, D Tarade Elife 11, e80774, 2022 | 21 | 2022 |
| Antimitotic activity of structurally simplified biaryl analogs of the anticancer agents colchicine and combretastatin A4 J McNulty, S van den Berg, D Ma, D Tarade, S Joshi, J Church, S Pandey Bioorganic & medicinal chemistry letters 25 (1), 117-121, 2015 | 18 | 2015 |
| Review of Cytotoxic CA4 Analogues that do not target microtubules: implications for CA4 development D Tarade, S Pandey, J McNulty Mini reviews in medicinal chemistry 17 (16), 1507-1514, 2017 | 13 | 2017 |
| Exploiting mitochondrial and oxidative vulnerabilities with a synthetic analog of pancratistatin in combination with piperlongumine for cancer therapy D Ma, T Gilbert, C Pignanelli, D Tarade, M Noel, F Mansour, M Gupta, ... The FASEB Journal 32 (1), 417-430, 2018 | 12 | 2018 |
| Deficiency in PHD2-mediated hydroxylation of HIF2α underlies Pacak-Zhuang syndrome FG Ferens, CC Taber, S Stuart, M Hubert, D Tarade, JE Lee, M Ohh Communications Biology 7 (1), 240, 2024 | 1 | 2024 |
| The long form of pVHL is artifactually modified by serine protease inhibitor AEBSF D Tarade, S He, J St‐Germain, A Petroff, A Murphy, B Raught, M Ohh Protein Science 29 (8), 1843-1850, 2020 | 1 | 2020 |
| Cathepsins L and B target HIF1α for oxygen-independent proteolytic cleavage S Stuart, D Tarade, M Ohh Scientific Reports 14 (1), 14799, 2024 | | 2024 |
| Engaging Gay, Bisexual, and Other Men Who Have Sex with Men (MSM) to Register As Stem Cell Donors in Canada: A Pilot Campaign D Tarade, K Williams, SV Kumar, SWS Chan, B Lam, K Farrokhi, ... 2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021 | | 2021 |
| Evolution of Metazoan Oxygen Sensing D Tarade University of Toronto (Canada), 2021 | | 2021 |
| Development and Evaluation of a Community of Practice to Support Stem Cell Donor Recruitment in Canada E Kum, A Hrycyshyn, G Jagelaviciute, AC Chen, I Baharmand, S Rihani, ... Blood 136, 25-26, 2020 | | 2020 |
| Correction: Corrigendum: Cancer Cell Mitochondria Targeting by Pancratistatin Analogs is Dependent on Functional Complex II and III D Ma, C Pignanelli, D Tarade, T Gilbert, M Noel, F Mansour, S Adams, ... Scientific Reports 8 (1), 46998, 2018 | | 2018 |
